AYTU Stock Overview · Trading at % below our estimate of its fair value · Earnings are forecast to grow % per year · Trading at good value compared to. Volume, K. Market Value, $M. Shares Outstanding, M. EPS (TTM), -$ P/E Ratio (TTM), N/A. Dividend Yield, N/A. Latest Dividend, N/A. AYTU stock results show that Aytu BioPharma beat analyst estimates for earnings per share and beat on revenue for the third quarter of The average one-year price target for Aytu BioPharma, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price target is the. Based on 1 Wall Street analysts offering 12 month price targets for Aytu BioScience in the last 3 months. The average price target is $ with a high forecast.
Aytu BioPharma Reports Fiscal First Quarter Financial Results. Q1 Adjusted EBITDA of $ million Rx Segment net revenue of $ million and Adjusted. Stay up-to-date on Aytu BioPharma, Inc. Common Stock (AYTU) news with the latest updates, breaking headlines, news articles, and more from around the web at. (NASDAQ:AYTU) Q2 Earnings Call Transcript February 14, Aytu BioPharma, Inc. beats earnings expectations. Reported EPS is $, expectations were $-. Aytu is committed to improving patients' health everywhere. Our prescription therapeutics help patients lead healthier and more fulfilling lives. Is Aytu Bioscience stock A Buy? Aytu Bioscience holds several negative signals and is within a wide and falling trend, so we believe it will still perform. There is no recent news for this security. Profile. MORE. Aytu BioPharma Global Business and Financial News, Stock Quotes, and Market Data and Analysis. Aytu BioPharma is a pharmaceutical company developing and commercializing novel therapeutics with a focus on pediatrics and pediatric-onset conditions. Webull offers Aytu Biopharma Inc stock information, including NASDAQ: AYTU news, and many more online research tools to help you make informed decisions. About Aytu BioPharma Inc Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel. Get Aytu Biopharma Inc (AYTU.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. Aytu BioScience (AYTU) reported Q3 earnings per share (EPS) of -$, beating estimates of -$ by %. In the same quarter last year, Aytu.
AYTU News · Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August , · Aytu BioPharma Announces Sale of Consumer Health. Aytu, KemPharm stocks plunge to pace Nasdaq decliners after share offerings. Shares of Aytu BioScience Inc. plummeted 33% and of KemPharm Inc. plunged 32%. Aytu BioPharma, Inc.'s stock symbol is AYTU and currently trades under NASDAQ. It's current price per share is approximately $ What are your Aytu BioPharma. Stock Price Targets ; High, $ ; Median, $ ; Low, $ ; Average, $ ; Current Price, $ View Aytu BioPharma, Inc. AYTU stock quote prices, financial information, real-time forecasts, and company news from CNN. What is the forecast for Aytu BioPharma (AYTU) stock? A. Aytu BioPharma has a consensus price target of $ Q. Current. Track Aytu BioPharma Inc (AYTU) Stock Price, Quote, latest community messages, chart, news and other stock related information. Discover real-time Aytu BioPharma, Inc. Common Stock (AYTU) stock prices, quotes, historical data, news, and Insights for informed trading and investment. Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products.
Stock analysis for Aytu BioPharma Inc (AYTU:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Aytu Biopharma Inc AYTU:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date10/18/23 · 52 Week Low · AYTU BioPharma, Inc. - AYTU STOCK NEWS · Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August , · Aytu BioPharma. On Friday 08/23/ the closing price of the Aytu BioPharma Inc Registered Shs share was $ on BTT. Compared to the opening price on Friday 08/23/ on. Aytu BioScience, Inc. (AYTU): $ · Get Rating · Component Grades · Latest AYTU News From Around the Web · Continue Researching AYTU.
Aytu Healight
Aytu BioScience Inc News & Analysis · Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August , · Aytu BioPharma sells. Aytu Biopharma, Inc. is a specialty pharmaceutical company, which focuses on identifying, acquiring, and commercializing novel products. Its products include. Aytu BioPharma News: This is the News-site for the company Aytu BioPharma on Markets Insider. Key Stock Data · P/E Ratio (TTM). N/A · EPS (TTM). $ · Market Cap. $ M · Shares Outstanding. M · Public Float. M · Yield. AYTU is not. News · Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August , · Express News | Aytu BioPharma Announces Sale Of Consumer.
How To Train Your Dragon Streaming Service | Cost Of Insurance For Learner Drivers